Pneumococcal vaccine conjugate 9-valent (Pfizer)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePneumococcal vaccine conjugate 9-valent (Pfizer)

Drug Alias NamePNCRM9Pneumococcal 9 valent CRM197 vaccine conjugate - Wyeth Vaccines

ClassificationVaccines > Development/production technology > Conjugated vaccineVaccines > Application > Therapeutic vaccineVaccines > Biological material > Bacterial vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPneumococcal Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesWyeth Pharmaceuticals Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesWyeth Pharmaceutical Co Ltd

Active IndicationsN/A

Inactive IndicationsPneumococcal Infections

Other Information

ATC CodeN/A